82 related articles for article (PubMed ID: 37940)
21. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
[TBL] [Abstract][Full Text] [Related]
22. Absorption, distribution and excretion of 14C-pirenzepine in rats. Accumulation characteristics after multiple dose regimen.
Kobayashi S; Kyui S; Yoshida T; Nagakura A; Oiwa Y; Matsumura R; Kohei H
Arzneimittelforschung; 1981; 31(4):679-90. PubMed ID: 6894697
[TBL] [Abstract][Full Text] [Related]
23. Absorption, distribution and excretion of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate in rats, dogs and monkeys.
Ando T; Momota K; Sugiyama M
Arzneimittelforschung; 1986 Aug; 36(8):1221-8. PubMed ID: 3778559
[TBL] [Abstract][Full Text] [Related]
24. [Effect of phenazepam on the body organs and systems of rats subjected to prolonged ethanol exposure].
Liubimov BI; Sorokina AV; Iavorskiĭ AN; Krylova AM; Boĭko SS
Farmakol Toksikol; 1983; 46(1):82-6. PubMed ID: 6130972
[TBL] [Abstract][Full Text] [Related]
25. The disposition and metabolism of a hypnotic benzodiazepine, quazepam, in the hamster and mouse.
Hilbert J; Pramanik B; Symchowicz S; Zampaglione N
Drug Metab Dispos; 1984; 12(4):452-9. PubMed ID: 6148212
[TBL] [Abstract][Full Text] [Related]
26. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
27. [2-14C-phenazepam metabolism in vitro].
Golovenko NIa; Zin'kovskiĭ VG
Farmakol Toksikol; 1979; 42(6):597-600. PubMed ID: 40817
[TBL] [Abstract][Full Text] [Related]
28. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
30. [Effect of phenazepam on sleep cycles in rats].
Voronina TA; Nerobkova LN
Farmakol Toksikol; 1981; 44(1):18-20. PubMed ID: 7196341
[TBL] [Abstract][Full Text] [Related]
31. The disposition and elimination of two sequential doses of 2,4,5,2',4',5'-hexachlorobiphenyl.
Gallenberg LA; Vodicnik MJ
Drug Metab Dispos; 1987; 15(3):363-6. PubMed ID: 2886312
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of ciprofloxacin. 2nd communication: distribution to and elimination from tissues and organs following single or repeated administration of [14C]ciprofloxacin in albino rats.
Siefert HM; Maruhn D; Scholl H
Arzneimittelforschung; 1986 Oct; 36(10):1503-10. PubMed ID: 3101707
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of 2-ethyl-1,3-hexanediol. II. Nonsystemic disposition following single percutaneous or peroral doses in Fischer 344 rats.
Frantz SW; Beskitt JL; Grosse CM; Tallant MJ; Ballantyne B
Drug Metab Dispos; 1992; 20(1):6-18. PubMed ID: 1346998
[TBL] [Abstract][Full Text] [Related]
34. Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers.
Prakash C; Cui D; Baxter JG; Bright GM; Miceli J; Wilner K
Drug Metab Dispos; 1998 May; 26(5):448-56. PubMed ID: 9571226
[TBL] [Abstract][Full Text] [Related]
35. The pharmacokinetics of nitrendipine. I. Absorption, plasma concentrations, and excretion after single administration of [14C]nitrendipine to rats and dogs.
Krause HP; Ahr HJ; Beermann D; Siefert HM; Suwelack D; Weber H
Arzneimittelforschung; 1988 Nov; 38(11):1593-9. PubMed ID: 3214442
[TBL] [Abstract][Full Text] [Related]
36. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
37. Absorption, distribution and excretion of radioactivity after a single intravenous or oral administration of [14C] glucosamine to the rat.
Setnikar I; Giachetti C; Zanolo G
Pharmatherapeutica; 1984; 3(8):538-50. PubMed ID: 6422479
[TBL] [Abstract][Full Text] [Related]
38. Disposition and metabolism of [14C]-haloperidol in rats.
Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
[TBL] [Abstract][Full Text] [Related]
39. Absorption, distribution and excretion of a new thienodiazepine derivative (Y-7131) in rats and mice.
Kato Y; Nishimine H
Arzneimittelforschung; 1978; 28(7):1170-3. PubMed ID: 39572
[TBL] [Abstract][Full Text] [Related]
40. Disposition of low doses of 14C-bisphenol A in male, female, pregnant, fetal, and neonatal rats.
Kurebayashi H; Nagatsuka S; Nemoto H; Noguchi H; Ohno Y
Arch Toxicol; 2005 May; 79(5):243-52. PubMed ID: 15902421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
